Trump to announce deal on weight loss drug prices
Digest more
() -Rhythm Pharmaceuticals said on Friday the U. Food and Drug Administration has extended the review period for ...
The Trump administration on Thursday announced its newest pharmaceutical agreement under its Most Favored Nation (MFN) policy, striking deals with Novo Nordisk and Eli Lilly to sell their GLP-1 ...
Novo Nordisk and Eli Lilly reached deals to lower GLP-1 drug costs for Medicare and Medicaid patients under Trump’s new ...
The Trump administration on Thursday rolled out a much-anticipated deal with drugmakers Eli Lilly and Novo Nordisk that aims ...
The top drug regulator at the Food and Drug Administration (FDA) resigned Sunday, according to officials, after being accused ...
The U.S. Food and Drug Administration said on Thursday it has awarded six more companies, including Eli Lilly and Novo ...
The dramatic shift in oversight comes at a time when the U.S. has never been more reliant on foreign food, which accounts for ...
The FDA has sent warning letters to 18 websites selling counterfeit or unapproved versions of Botox and similar injectable ...
The head of the U.S. Food and Drug Administration’s drug division, Dr. George F. Tidmarsh, resigned on November 2, 2025, one ...
New professional guidance to the nation's pediatricians advises against using a drug in children with autism that many families are clamoring for after it was hyped by federal officials.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback